GoSilico

Karlsruhe, Germany Founded: 2016 • Age: 10 yrs Acquired By Cytiva
Simulation software for in silico bioprocess development is provided.

About GoSilico

GoSilico is a Healthcare company based in Karlsruhe (Germany) founded in 2016, and was acquired by Cytiva in June 2021. Simulation software for in silico bioprocess development is provided. It operates in the Healthcare and Industrial Goods & Manufacturing sectors. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery.

Company details

GoSilico was founded in 2016 in Karlsruhe, Germany, within the bioprocess sector. ChromX simulation software has been developed for computer-aided in silico processes, particularly preparative liquid chromatography. Operations encompass model development, process optimization, characterization, and scale-up technology. These services support bioprocess efficiency in the pharmaceutical and biotech industries.

  • Headquarters Karlsruhe, Germany
  • Stage Acquired
  • Sectors
    Healthcare
    Industrial Goods & Manufacturing
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website gosilico.com
  • Social LinkedIn Facebook
  • Acquired by Cytiva (Jun 2021)
Key Metrics

Investors in GoSilico

GoSilico has secured backing from 1 investor. Prominent investors backing the company include Cytiva.

All
InvestorDescriptionFounded YearDomainLocation
Life science software and research products are provided online.
1968cytivalifesciences.comSheffield, United Kingdom
Premium access

Investor details for GoSilico

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of GoSilico

2 dated milestones of GoSilico across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded GoSilico is founded.
  2. Exit Acquired by Cytiva.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Gosilico

Cytiva Acquires German Software Maker GoSilico
Biopharminternational β€’ 5 years ago
Premium access

Complete news archive for GoSilico

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about GoSilico

GoSilico was founded in 2016.

GoSilico is headquartered in Karlsruhe, Germany. It is registered at Karlsruhe, Baden-wurttemberg, Germany.

GoSilico was founded in 2016 in Karlsruhe, Germany, within the bioprocess sector. ChromX simulation software has been developed for computer-aided in silico processes, particularly preparative liquid chromatography. Operations encompass model development, process optimization, characterization, and scale-up technology. These services support bioprocess efficiency in the pharmaceutical and biotech industries.

GoSilico has 1 investor. Key investors include Cytiva.

Yes. GoSilico was acquired by Cytiva in June 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available